MeiraGTx Holdings PLC (MGTX)

MeiraGTx Holdings PLC (MGTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $955M; returns 1 day -5.7%, 1 week -0.8%, 1 year +5.3%.

MeiraGTx Holdings PLC is a clinical-stage, vertically integrated gene therapy company focused on developing treatments for a range of inherited and acquired diseases. The company's business model is centered on advancing its proprietary pipeline and leveraging its in-house manufacturing capabilities to secure strategic partnerships, rather than generating revenue from product sales.

Groups MGTX belongs to

• Clinical Stage Biotech
• Gene Therapy
• Biotechnology
• Healthcare
• Clinical Stage
• Life Sciences
• Rare Diseases
• Ophthalmology
• Vertical Integration
• R&D
• Neuroscience

MGTX financial model: income statement, cash flow and balance sheet